… PCR-confirmed infected with SARS-CoV-2. Finally, we longitudinally measured hCoV and
SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients. Our studies indicate …

… SARS-CoV-2 S neutralization escape variants. Mechanistic studies showed that these
antibodies … COV2-2676 and COV2-2489 offered protection either as prophylaxis or therapy, and …

… from COVID-19 and tested seropositive for anti-SARS-CoV-2 antibodies have low rates of
SARS-CoV-2 … the strength and duration of such protection compared with that from vaccination. …

… their clinical use as recombinant monoclonal antibodies (mAbs) is being … antibodies against
SASR-CoV-2 and their protective activity have been clearly defined, their role in COVID-19 …

… -2 in rhesus macaques, and that cellular immune … to protection if antibody responses
are suboptimal. We also show that higher antibody titres are required for treatment of SARS-CoV-2 …

… correlates of protection using data from 171 cases of SARS-CoV-2 infection and 1,404
noncases, showing that higher anti-spike IgG, anti-RBD IgG, and neutralizing antibody titers are …

… antibody responses, even after accounting for severity. We conclude that SARS-CoV-2
infection elicits robust neutralizing antibody … SARS-CoV-2 neutralizing antibody was protective …

… Considering the important role of the antibody for the protective immunity shown in the
present study, we also tested the other forms of the spike protein for the optimal induction of …

… neutralizing antibody responses to SARS-CoV-2 with vaccine efficacy and bring researchers
and clinicians closer to having a correlate of protection for vaccines against COVID-19. …

… We carried out a subset analysis of antibody waning in symptomatic children with SARS-CoV-2
infection aged ≤ 15y (Fig. 2). In mild disease (none of the children had severe disease), …